|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/30 | |||
| A61K 45/06 |
| (11) | Number of the document | 2852409 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13729591.1 |
| Date of filing the European patent application | 2013-05-21 | |
| (97) | Date of publication of the European application | 2015-04-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/001503 |
| Date | 2013-05-21 |
| (87) | Number | WO 2013/174509 |
| Date | 2013-11-28 |
| (30) | Number | Date | Country code |
| PCT/EP2012/0022 | 2012-05-23 | WO |
| (72) |
SAHIN, Ugur, DE
TÜRECI, Özlem, DE
MITNACHT-KRAUS, Rita, DE
JACOBS, Stefan Denis, DE
UTSCH, Magdalena Jadwiga, DE
HEINZ, Cornelia Adriana Maria, DE
STADLER, Christiane Regina, DE
|
| (73) |
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb,
Freiligrathstrasse 12, 55131 Mainz,
DE
Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP |
| (54) | COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER |
| COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER |